Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05578742
Other study ID # 2022-A00649-34
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2023
Est. completion date April 2026

Study information

Verified date October 2022
Source University Hospital, Angers
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aim to compare the effect of Positive End Expiratory Pressure (PEEP) on ventilation/perfusion mismatch in two phenotypes of patients with moderate-to-severe Acute Respiratory Distress Syndrome (ARDS), characterized by their respiratory system elastance (Ers). Ventilation/perfusion mismatch will be assessed by Electrical Impedance Tomography (EIT).


Description:

Acute Respiratory Distress Syndrome (ARDS) is characterized by hypoxemia caused by inflammatory lung injury. Recent studies showed an important variability in ARDS phenotypes . The recent COVID-19 crisis highlighted the presence of ARDS patients with severe hypoxemia and normal respiratory system compliance, and retrospective series confirmed the existence of this atypical ARDS pattern also in non-COVID etiologies. The dissociation between mechanics and hypoxemia may be related to a specific diversity in the pattern of ventilation-perfusion matching (V/Q matching) among patients with normal compliance and ARDS. In patients with low compliance, V/Q mismatch may be characterized by right-to-left shunt, secondary to collapse of the gravity-dependent regions; while, in patients with normal compliance, V/Q mismatch may show a redistribution of blood flow to hypo-ventilated lung areas by larger dead space and impaired hypoxic vasoconstriction. These differences may also influence the response to PEEP in terms of gas exchange and lung protection . It may also explain the failure for high PEEP levels to improve significantly mortality in the global ARDS population (i.e., with patients' selection only based on hypoxemia). Electrical Impedance Tomography (EIT) is a device allowing to assess ventilation and perfusion distribution. Thus, EIT can be used to evaluate global and regional V/Q matching, and could be used to understand mechanisms of hypoxemia, especially in patients with normal mechanics and ARDS. The aim of this study is to assess V/Q matching according to these different ARDS phenotypes, and to evaluate the effects of PEEP in each one.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date April 2026
Est. primary completion date October 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 =200 mmHg at PEEP 5 cmH2O) - undergoing deep sedation - on controlled mechanical ventilation - between 24 hours and 5 days after intubation. Exclusion criteria: - age <18 years old; pregnancy - patient undergoing legal protection - contra-indications to EIT (e. g. severe chest trauma or wounds) - pneumothorax; patient undergoing ECMO - patient with BMI =35 kg/m2 - hemodynamic instability with MAP <60 mmHg despite vasopressors.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
PEEP increase
Positive End Expiratory Pressure (PEEP) will be increased from 5 to 15 cmH2O.
PEEP decrease
Positive End Expiratory Pressure (PEEP) will be decreased from 15 to 5 cmH2O.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in ventilation/perfusion mismatch between PEEP 5 and 15 cmH2O according to the two studied phenotypes Ventilation/perfusion (V/Q) mismatch will be assessed by Electrical Impedance Tomography (EIT). Mismatch is expressed in %. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in respiratory mechanics between PEEP 5 and 15 cmH2O according to the two studied phenotypes Plateau pressure and total PEEP will be aggregated to compute driving pressure (Plateau pressure minus total PEEP, all in cmH2O). Respiratory system compliance will be computed by dividing tidal volume by driving pressure (in mL.cmH2O-1; respiratory system resistance will be computed as the inverse of compliance; all these values will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in oxygenation between PEEP 5 and 15 cmH2O according to the two studied phenotypes PaO2 (in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in carbon clearance between PEEP 5 and 15 cmH2O according to the two studied phenotypes PaCO2 (in mmHg) will be assessed and compared between the two PEEP levels. Ventilatory ratio (no unit) will be derived from the PaCO2 values. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in dead space measured by capnometric volumetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes VCO2 (measured by Vcap, in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in dead space measured by calorimetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes VCO2 (measured by calorimetry, in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Difference in venous oxygen saturation between PEEP 5 and 15 cmH2O according to the two studied phenotypes SvO2 (in %) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
Secondary Correlation between V/Q mismatch markers and recruitability Recruitability will be assessed between 15 and 5 cmH2O by respiratory mechanics and EIT, as the recruited volumes value (in mL). R/I ratio will be derived from these data (no unit). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. immediately after each intervention
Secondary Correlations between V/Q mismatch assessed by EIT and dead space markers Dead space will be assessed by volumetric capnography (if available), venrtilatory ratio, and calorimetriy (if available). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. immediately after each intervention
Secondary Correlations between V.Q mismacth and overdisension and lung collapsus Overdistension (%) and lung collapsus (%) will be assessed during the Step 3, by EIT. These two values cannot be measured separately. V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. immediately after each intervention
Secondary Difference in stress index between PEEP 5 and 15 cmH2O according to the two studied phenotypes stress index (no unit) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. immediately after each intervention
See also
  Status Clinical Trial Phase
Completed NCT04435613 - Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients N/A
Enrolling by invitation NCT05020210 - Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Completed NCT04468971 - REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia Phase 1
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT04493242 - Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01949272 - Optimization of PEEP for Alveolar Recruitment in ARDS N/A
Not yet recruiting NCT01668368 - Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance N/A
Completed NCT01881061 - Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit N/A
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT05035589 - The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Recruiting NCT04764032 - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Completed NCT04556513 - Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Recruiting NCT06036056 - NMR Based Metabolomics Kinetics in ARDS Patients
Recruiting NCT04503876 - Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome N/A
Recruiting NCT04643691 - Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS Phase 2
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Not yet recruiting NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Recruiting NCT05056090 - Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome. N/A